Clinical Chemistry Standards
Genscript Corporation MonoRab NT-proBNP 10B11 mA
BNP and NT-proBNP are separated from precursor molecule proBNP via proteolytic processing The BNP and NT-proBNP level in blood are proportional to the severity of cardiac dysfunction They can be used for diagnosis of congestive heart failure (CHF)
Genscript Corporation MonoRab NT-proBNP 22B11 mA
BNP and NT-proBNP are separated from precursor molecule proBNP via proteolytic processing The BNP and NT-proBNP level in blood are proportional to the severity of cardiac dysfunction They can be used for diagnosis of congestive heart failure (CHF)
SIGMA ALDRICH FINE CHEMICALS BIOSCIENCES ACETALDEHYD-2 4-DNPH SLN 5X1ML
NC3665251 ACETALDEHYD-2 4-DNPH SLN 5X1ML
Genscript Corporation NT-proBNP 3B42HC
BNP and NT-proBNP are separated from precursor molecule proBNP via proteolytic processing The BNP and NT-proBNP level in blood are proportional to the severity of cardiac dysfunction They can be used for diagnosis of congestive heart failure (CHF)
ABclonal Technology Cardiac Troponin I (TNNI3) Rabbit pAb
Troponin I (TnI) is one of three subunits of the troponin complex in striated muscle, acting as the inhibitory component that blocks actin-myosin interactions to mediate muscle relaxation. This gene encodes the cardiac-specific isoform, expressed exclusively in heart tissue. Mutations are linked to familial hypertrophic cardiomyopathy type 7 (CMH7) and restrictive cardiomyopathy (RCM). TnI is a key biomarker for diagnosing heart failure and ischemic heart disease. Elevated troponin levels are also used to detect acute myocardial injury in moderate to severe COVID-19 cases and are associated with increased mortality in cardiovascular patients hospitalized with COVID-19.
Meso Scale Discovery RPLEX Hu Troponin I crdc ASYQP
The R-Plex Human Troponin I Cardiac Assay from Meso Scale Diagnostics is a multiplex immunoassay that quantitatively measures cardiac troponin I in human serum plasma and cell culture supernatant samples It utilizes electrochemiluminescence detection technology and provides high sensitivity a broad dynamic range and requires a low sample volume This assay allows for the rapid and efficient analysis of cardiac troponin I a biomarker used to aid in the diagnosis of acute myocardial infarction With a measuring range of 0 5-2500 pg/mL and an LLOQ of 1 1 pg/mL this assay kit enables the sensitive and accurate quantification of cardiac troponin I levels
Abcam D-AP5, NMDA glutamate site antagonist, 1MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. More active form of DL-AP5.
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-AP4, group III mGlu agonist, 50MG
MW 183.1 Da, Purity >99%. Selective group III mGlu agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-AP5, NMDA glutamate site antagonist, 100MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. More active form of DL-AP5.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP5, NMDA glutamate site antagonist, 100MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. Also available as the sodium salt (ab120271).
The product is subject to the following: Abcam Restricted Use Statement